University of Massachusetts Chan Medical School
Worcester, Massachusetts 10655
27 studies enrolling now · 63 studies all time
What they study most
AMN, AMN Gene Mutation, Abiraterone Acetate, Acute Stress Reaction, Allergic Contact Dermatitis, Amyotrophic Lateral Sclerosis, Androgens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Atrial Fibrillation, Autism, Autism Spectrum Disorder
Studies at this site
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised — Recruiting now
- Botulinum Toxin Therapy in Hidradenitis Suppurativa — Recruiting now
- A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
- A Study of Brenipatide in Adult Participants With Schizophrenia — Recruiting now
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease — Recruiting now
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis — Recruiting now
- A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
- RA-PRO PRAGMATIC TRIAL — Recruiting now
- A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia — Recruiting now
- ARISe at UMass Chan — Recruiting now
- A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy — Recruiting now
- A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
- A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30) — Recruiting now
- Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application — Recruiting now
- Testimonials and Navigation in Rheumatology — Recruiting now
- A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine — Recruiting now
- Asthma Link Effectiveness Trial — Recruiting now
- Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women — Recruiting now
- Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery — Recruiting now
- Promoting Improved Functioning Among People Experiencing Stressful Situations — Recruiting now
- Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation — Recruiting now
- Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients — Recruiting now
- PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis — Recruiting now
- EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease — Recruiting now
- Facilitation of Information eXchange for Shared Decision Making for Lung Cancer Screening — Enrolling by invitation
- A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) — Running, not enrolling
- An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Enrolling by invitation
- AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) — Running, not enrolling
- A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy — Running, not enrolling
- A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — Running, not enrolling
- Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation — Running, not enrolling
- An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) — Completed
- ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors — Running, not enrolling
- RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis — Running, not enrolling
- Social Media and Risk-reduction Training for Preterm Infant Care Practices — Starting soon
- A Culturally Tailored Dietary Intervention to Treat Crohn's Disease — Running, not enrolling
- Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis — Starting soon
- Reentry Assist (R-Assist) — Running, not enrolling
- Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM — Completed
- A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma — Running, not enrolling
- Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
- Radiofrequency Ablation After Total Knee Arthroplasty — Running, not enrolling
- Data Collection for Echocardiography-Based Software Assessment — Completed
- Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India — Running, not enrolling
- To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. — Completed
- A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN) — Stopped early
- A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants — Running, not enrolling
- REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 — Stopped early